Leptomeningeal disease (LMD) after resection of brain metastases: results of the multicenter SUBAROMA study - Quiz - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Outcomes of Leptomeningeal Disease Following Brain Metastasis Resection: Findings from the Multicenter SUBAROMA Trial

  • By

  • Laura Mühlhausen

  • Martin Kocher

  • Hanah Hadice Karadachi

  • Ulrich Sure

  • Yahya Ahmadipour

  • Levin Häni

  • Danial Nasiri

  • Tommaso Araceli

  • Martin Proescholdt

  • Nils Ole Schmidt

  • Andrea Cattaneo

  • Vera Nickl

  • Florian Scheichel

  • Franz Marhold

  • Stefan J. Grau

  • Christina A. Hamisch

  • Franz L. Ricklefs

  • Yahya Zghaibeh

  • Roland H. Goldbrunner

  • Stephanie T. Jünger

  • July 10, 2026

Share

Original Source(s)

Leptomeningeal disease (LMD) after resection of brain metastases: results of the multicenter SUBAROMA study

  • by Laura Mühlhausen, Martin Kocher, Hanah Hadice Karadachi, Ulrich Sure, Yahya Ahmadipour, Levin Häni, Danial Nasiri, Tommaso Araceli, Martin Proescholdt, Nils Ole Schmidt, Andrea Cattaneo, Vera Nickl, Florian Scheichel, Franz Marhold, Stefan J. Grau, Christina A. Hamisch, Franz L. Ricklefs, Yahya Zghaibeh, Roland H. Goldbrunner, Stephanie T. Jünger

  • July 10, 2026

Related Content

Predictors of Delayed and Omitted Postoperative Radiotherapy After Laryngectomy for pT4 Laryngeal Cancer

Beyond classical boundaries: rethinking ICU access in acute leukemia

Malignant transformation of lower-grade glioma: contrast enhancement, extent of resection, and the natural history under interval-censored analysis